>
Switch to:

Icon YoY EBITDA Growth

: -23.48% (As of Sep. 2021)
View and export this data going back to 1998. Start your Free Trial

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Icon's YoY EBITDA Growth for the quarter that ended in Sep. 2021 was -23.48%.

Icon's EBITDA per Share for the three months ended in Sep. 2021 was $1.81.


Icon YoY EBITDA Growth Historical Data

The historical data trend for Icon's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icon Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
YoY EBITDA Growth
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.00 10.91 10.57 13.97 -6.45

Icon Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
YoY EBITDA Growth Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.29 5.27 8.67 76.83 -23.48

Icon YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Icon's YoY EBITDA Growth for the fiscal year that ended in Dec. 2020 is calculated as:

YoY EBITDA Growth (A: Dec. 2020 )
=(EBITDA per Share (A: Dec. 2020 )-EBITDA per Share (A: Dec. 2019 ))/ | EBITDA per Share (A: Dec. 2019 ) |
=(8.64-9.236)/ | 9.236 |
=-6.45 %

Icon's YoY EBITDA Growth for the quarter that ended in Sep. 2021 is calculated as:

YoY EBITDA Growth (Q: Sep. 2021 )
=(EBITDA per Share (Q: Sep. 2021 )-EBITDA per Share (Q: Sep. 2020 )) / | EBITDA per Share (Q: Sep. 2020 )) |
=(1.805-2.359)/ | 2.359 |
=-23.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Icon YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Icon's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Icon Business Description

Icon logo
Industry
Traded in Other Exchanges
Address
South County Business Park, Leopardstown, Dublin, IRL, 18
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Icon Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)